Enhancement of lipid peroxidation and of the antitumor effect of hyperthermia upon combination with oral eicosapentaenoic acid

Cancer Lett. 2002 Nov 28;185(2):139-44. doi: 10.1016/s0304-3835(02)00262-8.

Abstract

The present study was designed to determine the effect of eicosapentaenoic acid (EPA) on the susceptibility of tumor cells to treatments that kill the cells by lipid peroxidation. Using AH109A carcinoma, a rat liver cancer, we measured EPA content, levels of antioxidants, and degree of lipid peroxidation in tumor tissue and normal liver tissue after oral administration of EPA. In the control group treated with distilled water, EPA in tumor tissue was lower than in normal liver tissue, suggesting that its content of polyunsaturated fatty acids (the substrates for lipid peroxidation) was inherently low. Levels of antioxidants also tended to be lower in tumor tissue. EPA level increased in both tumor and normal tissues after oral administration of EPA. At the same time, glutathione peroxidase (GSH-Px) increased in normal tissue, whereas tumor tissue displayed no increase in antioxidants; instead GSH decreased. The EPA-induced change in balance between substrates for lipid peroxidation and antioxidants suggested that tumor tissue might become more susceptible to lipid peroxidation than normal liver tissue. In fact, hyperthermia treatment did enhance lipid peroxidation and antitumor action. Our results indicate that oral EPA specifically increases the susceptibility of liver tumor tissue to lipid peroxidation, and hence enhance the antitumor effect of hyperthermia and prolongs survival.

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Animals
  • Antimetabolites, Antineoplastic / pharmacology
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / analysis
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Antioxidants / analysis
  • Arachidonic Acids / administration & dosage
  • Arachidonic Acids / analysis
  • Arachidonic Acids / pharmacology
  • Arachidonic Acids / therapeutic use*
  • Buthionine Sulfoximine / pharmacology
  • Buthionine Sulfoximine / therapeutic use
  • Carcinoma / drug therapy
  • Carcinoma / metabolism
  • Carcinoma / therapy*
  • Drug Screening Assays, Antitumor
  • Fatty Acids, Unsaturated / analysis
  • Glutathione Peroxidase / analysis
  • Hyperthermia, Induced*
  • Lipid Peroxidation / drug effects*
  • Liver / chemistry
  • Liver / drug effects
  • Liver Neoplasms, Experimental / drug therapy
  • Liver Neoplasms, Experimental / metabolism
  • Liver Neoplasms, Experimental / therapy*
  • Male
  • Oxidation-Reduction
  • Rats
  • Stimulation, Chemical
  • Thiobarbituric Acid Reactive Substances / analysis

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Antioxidants
  • Arachidonic Acids
  • Fatty Acids, Unsaturated
  • Thiobarbituric Acid Reactive Substances
  • Buthionine Sulfoximine
  • Glutathione Peroxidase